Study claims to show difference between male and female brains
Posted by
,
No Comments
">
Wednesday, February 16, 2005
Michael Gurian, psychologist and author of “What Could He Be Thinking?“, has claimed to identify approximately one hundred structural differences between male and female brains in a recent study. Gurian comments:
- “Men, because we tend to compartmentalize our communication into a smaller part of the brain, we tend to be better at getting right to the issue, the more female brain (will) gather a lot of material, gather a lot of information, feel a lot, hear a lot, sense a lot.“
One major structural difference that Gurian has made clear is that males generally have more activity in the mechanical centers of the brain, while women have more activity in centers of the brain dedicated to verbal communication and emotion. A clear example of this is the hypothetical situation of giving a child a toy. He explains it as such:
- “That doll becomes life-like to that girl, but you give it to a two-year-old boy and you are more likely, not all the time, but you are more likely than not to see that boy try to take the head off the doll. He thinks spatial-mechanical. He’s using the doll as an object.“
Another expert, Dr. Marianne Legato, says it all boils down to genetics, noting that the Y chromosome (which only males carry) has “at least 21 unique genes unique to males which control many of the body’s operations down to the level of the cells.”
Gurian agrees that culture is significant in brain development, but argues that biology plays an equally important role. He makes a point of how the MRI scans show that the female corpus callosum, the center of the brain which regulates communication between the brain’s hemispheres, is larger than the male’s. On the other hand, the scans also show that information flows more freely between the hemispheres of the male brain.
The exact role that brain structure plays in behavior, however, has been an area of considerable contention in science for literally hundreds of years. Early studies in craniometry conducted by Paul Pierre Broca were used to attempt to distinguish differences between human races, though have now been dismissed as scientific racism. The nature-nurture debate has raged for centuries in a variety of forms, without yet any clear resolution as to the role in which innate biological tendencies interact with environmental conditions or willed behavior. As such, studies relating to brain structure and claims to innate behavior often generate substantial controversy.
MIT anthropologist of science Joseph Dumit’s study of brain imaging in his book Picturing Personhood: Brain Scans and Biomedical Identity, noted that the apparent “transparency” of such pictures (the appearance that they can be easily interpreted by laymen, when they are often the source of ambiguity and dispute by even highly-trained neurosurgeons) has led to their proliferation as indicators of objective truth in media and in courts of law, and that such conclusions are often knowingly exaggerated by the specialists creating the images for better visual effect.
The timing of Gurian’s book comes on the heels of another controversy over gender differences sparked by comments made by Harvard president Lawrence Summers, who blamed low numbers of women in the sciences on genetic differences. Summers has been criticized by a large number of academics and scientists, as well as by many news publications, in the wake of what he was reported as saying during a conference on January 14.
No Comments
- Click Here For More Specific Information On:
- R&D Consultant
The average human life has grown significantly primarily thanks to vaccination. Vaccines have transformed public health throughout the globe, especially for kids. in the united states, among the various diseases like Influenza, Rotavirus, Hepatitis (Hepatitis A and Hepatitis B), Polio, DTap, HIB, Pneumococcal conjugate, Varicella, MMR and HPV, influenza is the most typical infection. Quadrivalent is the commonest flu vaccines in the united states, which was licensed in the year 2012. according to Renub Research, united states vaccine market is poised to reach US$ 11.4 Billion by 2026.
When disease germs enter your body, they start to reproduce. Your immune system recognizes these germs as foreign invaders and responds by making proteins called antibodies. These antibodies’ first job is to assist destroy the germs that are making you sick. they’ll not act fast enough to prevent you from becoming ill, but by eliminating the attacking germs, antibodies help you to get well.
The antibodies’ second job is to guard you against future infections. They continue to be in your bloodstream, and if the same germs ever try and infect you again — even after many years — they’re going to come to your defence. Only now that they’re experienced at fighting these particular germs, they can destroy them before they have an opportunity to create you sick. This is immunity. it’s why most of the people get diseases like measles or chickenpox just once, even though they could be exposed repeatedly during their lifetime.
Although influenza can catch anyone anytime in the year, usually it spreads between May to October. So in August National Immunization Awareness day is being celebrated to increase the awareness and also the importance of vaccination in the nation. These immunizations awareness and government initiatives have helped to prevent 2-3 million deaths annually consistent with the WHO. there’s no other health intervention as simple, powerful, and cost-effective as a ‘vaccine’.
A vaccine is a biological preparation that gives active acquired immunity against a selected disease. A vaccine consists of an agent that resembles or maybe a part of the disease-causing microorganism and is often made from weakened or killed kinds of the organism, its toxins, or one of its surface proteins. The agent triggers the body’s immune system to acknowledge the agent as a threat, destroy it, and to recognize further and destroy any of the microorganisms related to that agent that it should encounter in the future.
The scope of the vaccines market includes technology, disease indication, route of administration, patient type, and region. The market for vaccines is analyzed supported regions like North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the vaccines market emphasizing on various parameters like market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Request a Free Sample Copy of the report:
All the 10 Vaccines have been studied from 3 points
• Vaccines Market• Immunized Population (Infants)• Doses of Vaccines Administered
Vaccine Type – The Report Covers the Market, Immunized Population and Administered Doses of all the 10 diseases
1. Influenza Vaccines2. Retrovirus3. Hepatitis A & B4. Polio5. DTaP6. HIB7. Pneumococcal conjugate8. Varicella9. MMR10. HPV
All the company analysis has been covered from 4 Viewpoints
• Overview• Recent Developments• Revenue Analysis• Vaccinations Pipeline & Clinical Trials
Company Analysis
• GlaxoSmithKline, plc• Merck & Co• Sanofi Pasteur• Pfizer, Inc.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Contact Us:Renub ResearchPhone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)Email: info@renub.comWeb: Follow on Linkedin:
">
Marussia F1 test driver Maria de Villota seriously injured in testing accident
Posted by
,
No Comments
Tuesday, July 3, 2012
The Marussia F1 team’s test driver, Spaniard María de Villota, was taken to hospital by air ambulance today after a collision in testing at Duxford Aerodrome.
At the end of her first installation run, the car she was driving had a low-speed collision with the loading ramp of the team’s support truck. According to BBC Cambridgeshire presenter Chris Mann, the car “suddenly accelerated” into the rear of the vehicle. The Marussia team released a statement an hour and a half after the accident, stating that she had been transferred to hospital, and a further statement would be issued once her condition had been assessed.
A spokesman for the East of England ambulance service, Gary Sanderson, said de Villota had “[…] sustained life-threatening injuries and following treatment at the scene by paramedics, she has been taken to Addenbrooke’s Hospital for further care.” According to witnesses, she was motionless for about fifteen minutes as medical teams attended to her, but did move her hands before being taken away from the test track. Medical charity Magpas, whose volunteer paramedics attended the accident, reported she had sustained injuries to her head and face, and was in a ‘stable condition’ when she reached the hospital.
Marussia reported her as conscious later in the afternoon: “Since Maria’s arrival at the hospital at approximately 10.45am this morning, she has been receiving the best medical attention possible at the hospital, which is the region’s major trauma centre. Maria is conscious and medical assessments are ongoing. The team will await the outcome of these assessments before providing further comment. The team’s first priority at this time is Maria and her family.”
De Villota was announced as Marussia’s test driver in March, having prior experience driving for Alan Docking Racing in Superleague Formula in Spain.
